Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.

[1]  N. Savion,et al.  A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. , 1997, Thrombosis research.

[2]  K. Fox,et al.  Different effects of calcium antagonists, nitrates, and beta-blockers on platelet function. Possible importance for the treatment of unstable angina. , 1997, Circulation.

[3]  C. Yosefy,et al.  Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis. , 1996, Journal of human hypertension.

[4]  J. Moake,et al.  Platelets and shear stress. , 1996, Blood.

[5]  M. Muggeo,et al.  Cardiovascular Disease and Its Risk Factors in IDDM in Europe , 1996, Diabetes Care.

[6]  Z. Bloomgarden,et al.  Potential mechanisms promoting restenosis in diabetic patients. , 1996, Journal of the American College of Cardiology.

[7]  F. Gries,et al.  Exposure of Adhesion Molecules on Activated Platelets in Patients with Newly Diagnosed IDDM Is Not Normalized by Near-Normoglycemia , 1995, Diabetes.

[8]  M B Brown,et al.  A Practical Two-Step Quantitative Clinical and Electrophysiological Assessment for the Diagnosis and Staging of Diabetic Neuropathy , 1994, Diabetes Care.

[9]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[10]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[11]  U. Cogan,et al.  Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. , 1994, Metabolism: clinical and experimental.

[12]  J. Yudkin,et al.  “Spontaneous” Platelet Aggregation in Whole Blood in Diabetic and Non Diabetic Survivors of Acute Myocardial Infarction , 1993, Thrombosis and Haemostasis.

[13]  D. Baim,et al.  Restenosis after Arterial Injury Caused by Coronary Stenting in Patients with Diabetes Mellitus , 1993, Annals of Internal Medicine.

[14]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[15]  Charles L. Brown,et al.  Can restenosis after coronary angioplasty be predicted from clinical variables? , 1993, Journal of the American College of Cardiology.

[16]  J. Akkerman,et al.  The influence of lipoproteins on blood platelets. , 1993, American heart journal.

[17]  F. Gries,et al.  Platelets in Diabetes: The Role in the Hemostatic Regulation in Atherosclerosis , 1993, Seminars in thrombosis and hemostasis.

[18]  P. Winocour Platelet Abnormalities in Diabetes Mellitus , 1992, Diabetes.

[19]  F. Ferris Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. , 1992, JAMA.

[20]  D. Bareford,et al.  The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension , 1992, Journal of hypertension.

[21]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[22]  J. Muller,et al.  Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men. , 1992, The American journal of cardiology.

[23]  K Watanabe,et al.  The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. , 1991, The Journal of clinical investigation.

[24]  D. Betterridge,et al.  Comparison of the Effects of Carvedilol, Propranolol, and Verapamil on in vitro Platelet Function in Healthy Volunteers , 1991, Journal of cardiovascular pharmacology.

[25]  P. Elwood,et al.  Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. , 1991, Circulation.

[26]  J. Schapiro,et al.  Platelet hyperreactivity and prognosis in survivors of myocardial infarction. , 1990, The New England journal of medicine.

[27]  B. Clarke,et al.  Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients. , 1989, Diabete & metabolisme.

[28]  A. Remaley,et al.  Evaluation of the clinical utility of platelet aggregation studies , 1989, American journal of hematology.

[29]  A. Barrett,et al.  Effect of methotrexate on relapse after bone-marrow transplantation for acute lymphoblastic leukaemia , 1989 .

[30]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[31]  S. Feman,et al.  Thromboxane biosynthesis and platelet function in type I diabetes mellitus. , 1988, The New England journal of medicine.

[32]  M. Aviram,et al.  Platelet Lipoprotein Interactions , 1988, Seminars in thrombosis and hemostasis.

[33]  B. Howard,et al.  Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.

[34]  P. Halushka,et al.  Do Platelets Have Anything To Do With Diabetic Microvascular Disease? , 1983, Diabetes.

[35]  J. P. Moulin,et al.  ABNORMALITIES OF ERYTHROCYTE DEFORMABILITY AND PLATELET AGGREGATION IN INSULIN-DEPENDENT DIABETICS CORRECTED BY INSULIN IN VIVO AND IN VITRO , 1982, The Lancet.

[36]  P. Halushka,et al.  PLATELET FUNCTION IN DIABETES MELLITUS , 1980, British journal of haematology.

[37]  P. Steele,et al.  Effects of Dietary and Pharmacologic Alteration of Serum Lipids on Platelet Survival Time , 1978, Circulation.

[38]  A. Basten,et al.  Letter: Lupus erythematosus and brain scanning. , 1975, Annals of internal medicine.

[39]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .

[40]  H. Kwaan,et al.  Increased platelet aggregation in diabetes mellitus. , 1972, The Journal of laboratory and clinical medicine.

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.